Open | 0.56 |
Previous Close | 0.575 |
Day Range | 0.54 - 0.65 |
52-Week Range | 0.48 - 136.80 |
All-Time High | 535.00 |
Avg. Volume (50-day) | 1,192,310.9 |
EPS (TTM) | -19.5628 |
Next Earnings Date | 2025-05-13 (AMC) |
Last Earnings Date | 2025-03-27 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -0.0300 |
PEG Ratio | - |
Price to Book | 0.47 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 2.240 M |
Share Float (%) | 1.92 M |
% Held by Institutions | 10.71 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 0.72 (-10.76%) |
+/- SMA(50) | 1.12 (-42.63%) |
+/- SMA(200) | 7.63 (-91.58%) |
5-Day Perf. | +6.62% |
1-Month Perf. | -41.06% |
3-Month Perf. | -86.35% |
6-Month Perf. | -95.37% |
YTD Perf. | -87.78% |
1-Year Perf. | -99.5% |
RSI(14) | 35.33 |
ATR(14) | 0.13 |
ADX(14) | 13.46 |
Beta (5Y) | - |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.
VINC has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
P&F Long Tail Down |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.